The intracellular bacterial pathogen Listeria monocytogenes produces phospholipases C (PI-PLC and PC-PLC) and the pore-forming cytolysin listeriolysin O (LLO) to escape the phagosome and replicate within the host cytosol. We found that PLCs can also activate the phagocyte NADPH oxidase during L. monocytogenes infection, a response that would adversely affect pathogen survival. However, secretion of LLO inhibits the NADPH oxidase by preventing its localization to phagosomes. LLO-deficient bacteria can be complemented by perfringolysin O, a related cytolysin, suggesting that other pathogens may also use pore-forming cytolysins to inhibit the NADPH oxidase. Our studies demonstrate that while the PLCs induce antimicrobial NADPH oxidase activity, this effect is alleviated by the pore-forming activity of LLO. Therefore, the combined activities of PLCs and LLO on membrane lysis and the inhibitory effects of LLO on NADPH oxidase activity allow L. monocytogenes to efficiently escape the phagosome while avoiding the microbicidal respiratory burst.
INTRODUCTION
Listeria monocytogenes is a Gram-positive bacterial pathogen that has adapted to intracellular infection within its host (Schnupf and Portnoy, 2007) . Upon entry into host cells, bacteria can escape from the phagosome through the activity of three virulence factors, listeriolysin O (LLO), a phosphatidylinositolspecific phospholipase C (PI-PLC), and a broad-range phospholipase C (PC-PLC). The pore-forming activity of LLO has been shown to prevent acidification of phagosomes in macrophages, thereby delaying their fusion with lysosomes prior to mediating phagosome escape (Shaughnessy et al., 2006) . PLCs have been shown to directly disrupt membranes through hydrolysis of phospholipids and in part through the activation of signal transduction cascades as a result of diacylglycerol production (Goebel and Kuhn, 2000; Goldfine et al., 1993) . Thus, these virulence factors contribute to the ability of L. monocytogenes to escape from the phagosome by different mechanisms.
The NOX2 nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (also referred to as gp91 phox ; phagocyte oxidase) plays a key role in immune responses via the production of reactive oxygen species (ROS) (Lam et al., 2010) . The loss of NADPH oxidase activity in mice lacking the gp91 phox subunit (gp91 phoxÀ/À ) results in increased replication of L. monocytogenes during the first 24 hr of infection compared to wild-type animals (Dinauer et al., 1997; Shiloh et al., 1999) . In vitro studies suggest that the NOX2 NADPH oxidase limits escape of L. monocytogenes from the phagosome in macrophages (Myers et al., 2003) . To ensure survival in host cells, a number of pathogens have evolved mechanisms to inhibit ROS production by the NOX2 NADPH oxidase (Allen et al., 2005; Blanchard et al., 2003; Boncompain et al., 2010; Keith et al., 2009; McCaffrey and Allen, 2006; Mott et al., 2002; Siemsen et al., 2009) . Salmonella enterica serovar Typhimurium has been shown to inhibit NOX2 NADPH oxidase delivery to bacteria-containing phagosomes (Vazquez-Torres et al., 2000) . However, total cellular ROS production by the NOX2 NADPH oxidase is unaffected in Salmonella-infected cells. These findings indicate that local inhibition of the NOX2 NADPH oxidase at phagosomes allows intracellular growth of these bacteria. The virulence factors used by Salmonella to mediate this phenotype are not known. Indeed, despite intensive research in this area, the mechanisms by which bacterial pathogens alter NOX2 NADPH oxidase activity during infection remain unclear.
Previously, it was shown that L. monocytogenes-infected neutrophils generate ROS 10 min postinfection (p.i.) (Sibelius et al., 1999) . However, exploration of the dynamics and localization of ROS production during L. monocytogenes infection have been limited. Since L. monocytogenes escape from the phagosome is a slow process (beginning 30 min p.i.) (de Chastellier and Berche, 1994) , Alvarez-Dominguez and colleagues suggested that these bacteria may employ mechanisms to inhibit the NADPH oxidase during infection (Prada-Delgado et al., 2001) . However, this hypothesis remains untested. Owing to the importance of the NOX2 NADPH oxidase in innate immunity, we examined ROS production in L. monocytogenes-infected macrophages, a cell type colonized by these bacteria during systemic infection. We demonstrate that L. monocytogenes, via the activity of LLO, can inhibit phagosomal production of ROS by the NOX2 NADPH oxidase.
RESULTS

LLO Inhibits Intracellular ROS Production by the NOX2 NADPH Oxidase
We performed dynamic measurements of intracellular and extracellular ROS production in bone marrow-derived macrophages (BMDMs) using luminol or isoluminol, respectively (Figures 1A and 1B) . During infection by wild-type L. monocytogenes, both intracellular and extracellular ROS production peaked at 10 min p.i. and decreased at later time points (Figures 1A and 1B) . Treatment of cells with phorbol 12-myristate 13-acetate (PMA), a known activator of the NOX2 NADPH oxidase, served as a positive control (see Tables S1A and S1B available online) . These findings demonstrate that L. monocytogenes can induce rapid activation of the NOX2 NADPH oxidase in leukocytes, consistent with previous observations (Sibelius et al., 1999) .
Given that oxidative stress results in an upregulation of LLO (Makino et al., 2005) , a virulence factor that inhibits phagosome maturation (Shaughnessy et al., 2006) , we hypothesized that LLO may participate in a specific bacterial response to ROS. To test this hypothesis, we examined ROS production in cells infected with LLO-deficient bacteria (DLLO, lacking the hly gene). We observed significantly higher intracellular ROS production in DLLO-infected cells compared to wild-type infected (A and B) ROS production was assessed via (A) luminol or (B) isoluminol assay. BMDMs were infected at an moi of 10 with wild-type (WT) or DLLO bacteria. The figures show data from one representative experiment done in duplicate where each data point represents the average and range. The experiment was performed a total of three independent times, and the average and SEM are tabulated in Tables S1A and S1B. (C) RAW 264.7 macrophages were treated with PMA or infected with the indicated bacterial strain (moi of 10) with or without DPI. Intracellular ROS production was assessed via flow cytometry with CM-H 2 DCFDA, which was added 30 min p.i., and cells were analyzed at 60 min p.i. Flow cytometry analysis was conducted on live cell populations gated against a stained untreated control (red). Representative plots are shown. (E) RAW 264.7 macrophages were treated with the indicated agents for 60 min, and CM-H 2 DCFDA dye was used to measure ROS production. Quantification of the percentage of ROS + cells was done using flow cytometry. Bars represent mean ± SEM from three independent experiments. cells at 40-70 min p.i. ( Figure 1A and Table S1A ). Addition of the flavoprotein inhibitor diphenyliodonium (DPI, a known NADPH oxidase inhibitor) prevented ROS production in DLLO-infected cells (Tables S1A and S1B ). In contrast, the kinetics of extracellular ROS production were similar upon infection with wild-type or DLLO L. monocytogenes ( Figure 1B , Table S1B ). These observations suggest that LLO inhibits intracellular ROS production. We further examined intracellular ROS production using 5-(and-6)-chloromethyl-2-7-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA) in RAW 264.7 macrophages. Cells were stimulated with PMA, or infected with either wild-type or DLLO bacteria, CM-H 2 DCFDA was added 30 min p.i., and the cells were examined by flow cytometry at 1 hr p.i. As expected, treatment of cells with PMA resulted in robust ROS production ( Figures 1C and 1D) . Consistent with the luminol assay, we observed little ROS production in wild-type infected cells but high levels of ROS production in DLLO-infected cells, comparable to those attained by stimulation with PMA ( Figures 1C  and 1D ). We also measured intracellular superoxide production using the nitroblue tetrazolium (NBT) reduction assay. DLLO bacteria induced a marked production of superoxide in RAW 264.7 macrophages, while infection with wild-type bacteria did not ( Figure S1A ).
To further examine the role of LLO, we employed an LLO-deficient strain that inducibly expresses LLO (iLLO) in response to isopropyl b-D-1-thiogalactopyranoside (IPTG). In the absence of IPTG, iLLO bacteria triggered ROS production. However, in the presence of IPTG, iLLO bacteria produced significantly less ROS upon infection ( Figure S1A ). Addition of purified LLO to human neutrophils was sufficient to inhibit PMA-induced ROS production ( Figure S1B ) at concentrations that did not cause cell toxicity ( Figure S1C ). Therefore, LLO is both necessary and sufficient for inhibition of intracellular ROS production by the NADPH oxidase.
To visualize the localization of ROS production during L. monocytogenes infection, we employed transmission electron microscopy (TEM) with cerium chloride. IgG-coated 3.8 mm latex beads were fed to RAW 264.7 macrophages as positive controls of phagosomal ROS production. A dark cerium precipitate was observed in phagosomes containing latex beads, indicative of ROS production in this compartment (Figures 2A, 2B , and 2G); accordingly, formation of the precipitate was inhibited by DPI treatment ( Figures 2C, 2D , and 2G). ROS production was not observed in phagosomes containing wild-type L. monocytogenes (Figures 2F and 2G) . However, marked cerium precipitation was observed in phagosomes containing DLLO bacteria (Figures 2E and 2G) . Together, these results indicate that LLO inhibits NOX2 NADPH oxidase-dependent ROS production in the phagosome.
L. monocytogenes PLCs Contribute to the Induction of ROS Production by the NOX2 NADPH Oxidase
The observation that DLLO bacteria induced high levels of intracellular ROS production, comparable to those observed in cells treated with PMA, suggested that bacterial products have the capacity to promote NOX2 NADPH oxidase activity in the absence of LLO. It was previously shown that PLCs from Clostridium perfringens, Pseudomonas aeruginosa, and Bacillus cereus are linked to activation of the NOX2 NADPH oxidase 
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Listeria Modulates NADPH Oxidase Activity (Styrt et al., 1989; Titball, 1993) . These enzymes generate diacylglycerol, a cofactor for activation of protein kinase C (PKC), which contributes to NOX2 NADPH oxidase activation via the phosphorylation of p47 phox (Fontayne et al., 2002) . Similarly, L. monocytogenes PLCs have been shown to generate diacylglycerol and activate PKC during infection of macrophages (Camilli et al., 1993; Goldfine et al., 1993 ). Therefore we hypothesized that L. monocytogenes PLCs may activate the NOX2 NADPH oxidase in the absence of LLO.
To test this hypothesis, we examined whether L. monocytogenes PLCs are required for ROS production. In contrast to DLLO bacteria, a strain lacking LLO and both PLCs (DLLO DPI-PLC DPC-PLC; lacking hly, plcA, and plcB genes) produced little intracellular ROS (Table S1A and Figure 1D ). Similarly, ROS production was not observed in phagosomes containing DLLO DPI-PLC DPC-PLC bacteria, as determined by the cerium precipitation assay ( Figure 2G ). Infection with a strain that lacks both PLCs (DPI-PLC DPC-PLC), but expressing LLO, resulted in ROS production comparable to that of wildtype bacteria ( Figure 1D ). These results indicate that LLO inhibits PLC-mediated NOX2 NADPH oxidase-dependent ROS production in the phagosome.
Next, we treated cells with purified PI-PLC and observed a significant induction of ROS production that was inhibited by the PKC inhibitors Rottlerin and GÖ 6983 ( Figure 1E ). ROS production by PI-PLC was also inhibited by concurrent treatment with purified LLO. These results suggest that PI-PLC is sufficient to drive NOX2 NADPH oxidase activation by stimulating PKC and that LLO is sufficient to inhibit this deleterious consequence of PLC activity. This is consistent with a previous finding that L. innocua expressing PI-PLC induces greater ROS production than wild-type L. innocua in neutrophils (Sibelius et al., 1999) . However, L. monocytogenes mutants that only express PI-PLC (and not PC-PLC or LLO) or PC-PLC (and not PI-PLC or LLO) do not induce significant ROS production (Figure S1D ). These observations suggest that both PLCs are required to mediate ROS production in the context of L. monocytogenes infection. However, higher doses of PI-PLC may be sufficient to drive NOX2 NADPH oxidase activation. Collectively, our results suggest that bacterial PLCs induce intracellular ROS production and that LLO inhibits this deleterious consequence of PLC activity.
LLO-Deficient Bacteria Survive in NOX2 NADPH Oxidase-Deficient Macrophages
The relevance of LLO-mediated inhibition of the NOX2 NADPH oxidase to intracellular L. monocytogenes survival/replication was determined by gentamicin protection assays using BMDM isolated from C57BL/6 and gp91 phoxÀ/À mice. The number of intracellular DLLO bacteria decreased over time in C57BL/6 BMDM ( Figure 3A) , consistent with previous observations (Alberti-Segui et al., 2007) . In contrast, DLLO bacteria displayed extended survival in gp91 phoxÀ/À BMDM ( Figure 3A ). Wild-type L. monocytogenes replicated at a similar rate in both C57BL/6 and gp91 phoxÀ/À BMDMs ( Figure 3B ). DLLO bacteria that were complemented by expression of LLO (DLLO + LLO) displayed a replication profile similar to that of wild-type bacteria ( Figure S2A ).
LLO-Deficient Bacteria Survive in NOX2 NADPH
Oxidase-Deficient Mice The in vivo relevance of LLO-mediated inhibition of the NOX2 NADPH oxidase was examined in C57BL/6 and gp91
phoxÀ/À mice. Wild-type L. monocytogenes replicated significantly over the course of 24 hr in both C57BL/6 and gp91 phoxÀ/À mice (Figure S2B) . The bacterial load at 24 hr was higher in gp91 phoxÀ/À compared to C57BL/6 mice ( Figures S2B and S2C) , as previously reported (Dinauer et al., 1997) . However, clearance of 
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Listeria Modulates NADPH Oxidase Activity DLLO bacteria was significantly impaired in the gp91 phoxÀ/À mice as compared to C57BL/6 mice ( Figures 3C and 3D) . Consistent with this result, more granulomas were observed at 24 hr p.i. in the livers of gp91 phoxÀ/À mice infected with DLLO bacteria than in C57BL/6 mice ( Figure 3E ). These results indicate that LLO-mediated inhibition of NADPH oxidase activity is required for L. monocytogenes survival both in vitro and in vivo.
LLO Inhibits NOX2 NADPH Oxidase Assembly at the Phagosome
The NOX2 NADPH oxidase is composed of a transmembrane heterodimer of gp91 phox and p22 phox , and regulatory cytosolic subunits, including p40 phox , p47
phox , p67 phox , and the small GTPase Rac2. We hypothesized that LLO inhibits ROS production by preventing proper localization of NOX2 NADPH oxidase components to the phagosome. To test this hypothesis, human primary macrophages were infected with GFP-expressing wildtype or DLLO bacteria and immunostained for p22 phox (Figure 4B ), p47 phox , or p67 phox ( Figure S3 ). IgG-opsonized sheep red blood cells were employed as a positive control for localization of the NOX2 NADPH oxidase to phagosomes ( Figure 4A , Figures S3A and S3C ). We observed minimal colocalization between intracellular wild-type bacteria and the NOX2 NADPH oxidase components tested ( Figures 4B and 4C , Figures S3B  and S3D ). In contrast, we observed more than a 3-fold increase in colocalization between intracellular DLLO bacteria and all of the NOX2 NADPH oxidase components tested ( Figures 4B and  4C , Figures S3B and S3D ). These observations demonstrate that LLO prevents NOX2 NADPH oxidase assembly at the phagosome.
Perfringolysin O Expression Can Complement NOX2 NADPH Oxidase Inhibition by LLO-Deficient Bacteria
We next determined whether, like LLO, other bacterial poreforming cytolysins could also inhibit the NOX2 NADPH oxidase. We used DLLO bacteria expressing perfringolysin O (PFO) from C. perfringens under a tightly controlled IPTG-inducible promoter (iPFO). In the absence of IPTG, iPFO-infected cells (D) Superoxide production by RAW 264.7 macrophages was measured by NBT reduction assay. Cells were either treated with PMA or infected at moi 10 with wild-type or DLLO bacteria for 30 min, followed by NBT treatment. Cells were also infected with iPFO, a complemented strain of DLLO that expresses PFO under an IPTG-inducible promoter. Graph represents mean ± SEM from three independent experiments. (E) Cells were either treated with PMA or infected at moi 10 with wild-type or DLLO bacteria for 30 min, followed by cerium chloride treatment. TEM analysis was employed to quantify the percentage of phagosomes that were cerium perhydroxide precipitate positive. One hundred phagosomes were assessed from each of the four independent experiments. Bars represent mean ± SEM. All scale bars are 10 mm. generated significant amounts of superoxide, similar to amounts generated by DLLO-infected cells ( Figure 4D ). However, upon IPTG induction, superoxide production was inhibited. The same effect was observed in bacteria-containing phagosomes by TEM analysis of cerium precipitates ( Figure 4E ). Since PFO can complement LLO for inhibition of NOX2 NADPH oxidase, these results suggest that the inhibition of ROS production may be a common strategy used by other bacteria that secrete pore-forming cytolysins.
DISCUSSION
Here we provide evidence that L. monocytogenes can modulate intracellular NOX2 NADPH oxidase activity during infection. Upon invasion, L. monocytogenes produces PLCs and LLO, which mediate bacterial phagosome escape. Production of diacylglycerol by PLCs has been implicated in phagosome escape by L. monocytogenes (Grundling et al., 2003) . However, diacylglycerol can also activate the NOX2 NADPH oxidase through activation of PKC (Dang et al., 2001) . Therefore, the induction of antibacterial ROS by PLCs is a potentially deleterious consequence of the mechanism that the bacteria utilize to promote phagosome escape in host cells. Here we show that ROS production between 40 and 70 min p.i. can be triggered by bacterial PLCs during infection by DLLO bacteria. The mechanism(s) by which bacterial PLCs contribute to NADPH oxidase activation in phagosomes remains to be established. Countering the potentially deleterious effect of PLCs, we find that LLO plays a key role in inhibiting the NOX2 NADPH oxidase between 40 and 70 min p.i. by blocking its localization to phagosomes. Therefore, one consequence of LLO pore formation is inhibition of PLC-stimulated ROS production, in addition to its role in phagosome escape and other virulence functions (Schnupf and Portnoy, 2007) . We find that LLO has no significant impact on ROS production at 10 min p.i. (Figures 1A and 1B , Tables S1A and S1B), which is known to be mediated, at least in part, through L. monocytogenes peptidoglycan stimulation (Remer et al., 2005) . In contrast to our findings, expression of LLO by L. innocua was found to enhance ROS production during 10 min infection of human neutrophils (Sibelius et al., 1999) , so we cannot rule out the possibility that LLO may activate the NADPH oxidase under some experimental conditions. How does LLO inhibit the NADPH oxidase in phagosomes? To begin to explore this question, we examined signaling events linked to activation of the NADPH oxidase in L. monocytogenesinfected cells. We observed that phosphorylation of the p40 phox subunit of the NADPH oxidase occurs in macrophages infected with both wild-type and DLLO bacteria ( Figure S4A ). The activities of p38, AKT, ERK1/2, and PKCd are required for NADPH oxidase activity (Bey et al., 2004; Chen et al., 2003; Dang et al., 2003; Dekker et al., 2000; Dewas et al., 2000; Fontayne et al., 2002) . However, we observed variability in these responses, and our results from three independent experiments did not show any significant differences in the activation of these kinases (as judged by phosphorylation of active-site residues) between wild-type or DLLO-infected macrophages ( Figures  S4B-S4E ). These findings indicate that LLO does not block the signaling that leads to NADPH oxidase activation, and instead suggest that it inhibits localization of the oxidase to phagosomes. Indeed, this is consistent with our observation that extracellular ROS production by the NADPH oxidase activation is not affected by LLO during L. monocytogenes infection ( Figure 1B , Table S1B ).
It is intriguing that both L. monocytogenes (reported here) and Salmonella enterica serovar Typhimurium (Vazquez-Torres et al., 2000) have evolved mechanisms to inhibit NADPH oxidase activity at phagosomes, allowing their intracellular colonization, but without globally disrupting ROS production by this system. It is possible that both pathogens exploit extracellular ROS-mediated signaling to promote inflammatory responses while locally inhibiting the microbicidal actions of these molecules.
These studies reveal how L. monocytogenes initiates a dynamic, and in this case antagonistic, set of signals in host cells via its virulence factors to allow for optimal bacterial growth and survival during infection. The observation that PFO can also mediate a similar inhibition of NOX2 NADPH oxidase suggests that inhibition of ROS production may be a conserved consequence of pore-forming cytolysin activity. Since PLCs and pore-forming cytolysins are encoded by a wide range of bacterial pathogens, this model may be applicable to several pathogenic species.
EXPERIMENTAL PROCEDURES Bacterial Strains and Culture Conditions
The L. monocytogenes strains used are listed in the Supplemental Information.
Macrophage Generation and Culture Conditions RAW 264.7 macrophages were purchased from American Type Culture Collection (Rockville, MD). RAW 264.7 cells were maintained in DMEM growth medium (HyClone) supplemented with 10% FBS (Wisent) at 37 C in 5% CO 2 without antibiotics. All experimental protocols involving mice were approved by the Animal Care Committee of The Hospital for Sick Children. Mice were euthanized by cervical dislocation. For BMDM, the femur and tibia were removed, cleansed of muscle fibers, and cut distally. The bone marrow was then removed via a 10 s pulse of centrifugation at 2000 rpm. The resulting cells were centrifuged at 1500 rpm for 5 min, washed with growth media, and plated on 10 cm tissue culture dishes. Media was replaced with fresh RPMI growth media (see below) every 3 days. Typically, 10 8 BMDMs were recovered after 7 days. Murine macrophages were maintained in RPMI-1640 medium (Wisent) supplemented with 10% FBS (Wisent), 5% sodium pyruvate (Invitrogen), 5% pen/strep (Invitrogen), 5% nonessential amino acids (Invitrogen), and 0.5 mM b-mercaptoethanol (Invitrogen). BMDMs were differentiated in 30% L929-conditioned media. L929-conditioned medium was generated by growing L929 cells (ATCC) in 150 cm 2 flasks at an initial density of 1 3 10 8 cells per flask in growth media as described above for use with RAW 264.7 cells. After 3 days, confluency was reached, and the growth media was substituted with DMEM alone. After 7-10 days, culture supernatant was collected and centrifuged at 1,500 rpm for 5 min, aliquoted, and stored at À20 C. Human macrophages were prepared as previously described (McGilvray et al., 2000) .
In Vivo Infection
Three-to five-week-old C57BL/6J and gp91 phoxÀ/À (Cybb/tm1d) mice were purchased from Jackson Laboratory. Mice were infected via intravenous injection in the lateral tail vein with wild-type L. monocytogenes at 5 3 10 4 colonyforming units (cfus) in 200 ml of PBS, and DLLO bacteria at 1 3 10 9 cfu in 200 ml of PBS. Mice were sacrificed at indicated time points, and the livers were obtained. The right lobes of the livers were fixed with formalin, embedded, and 3 mm sections stained with hematoxylin and eosin (H&E). The left lobes were homogenized in sterile PBS for cfu quantification from serial dilutions on BHI-agar plates. . Serial dilutions of the lysates were plated on BHI-agar plates and incubated 14-16 hr for subsequent quantification of cfus.
Cell Host & Microbe
Immunofluorescence and Antibodies
Immunostaining was conducted as previously described (Brumell et al., 2001) . In brief, after infections, human macrophages were fixed using 2.5% paraformaldehyde for 10 min at 37 C. Extracellular L. monocytogenes were detected by immunostaining prior to permeabilization. Cells were then permeabilized and blocked using 0.2% saponin with 10% normal goat serum 14-16 hr at 4 C, and staining for intracellular bacteria, p22 phox , p47 
